Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened ...

Patients urged to carry extra batteries as Medtronic recall affects 24,595 insulin pumps that may stop delivering insulin ...

Many of the top large-cap device makers reported relatively rosy fourth-quarter earnings while issuing 2023 guidance that was above analyst expectations.

Stay informed and make data-driven decisions with our Ratings Table. One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases.

Medtronic is a compelling investment with its diverse revenue streams, strong growth, and promising product pipeline at an ...

"Medtronic’s diabetes care division suffers setback from insulin pump recall" was originally created and published by Medical ...

Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...

Analyst Nico Chen of DBS maintained a Hold rating on Medtronic (MDT – Research Report), retaining the price target of $90.00. Nico Chen ...

Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the ...